Log in
Enquire now
‌

US Patent 7332581 Polypeptide variants with altered effector function

Patent 7332581 was granted and assigned to Genentech on February, 2008 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributors
Is a
Patent
Patent
0
Current Assignee
Genentech
Genentech
0
Date Filed
June 22, 2005
0
Date of Patent
February 19, 2008
0
Patent Application Number
11158839
0
Patent Citations Received
‌
US Patent 12134649 Anti-B7-H4 antibodies and immunoconjugates
0
‌
US Patent 12103982 T cell activating bispecific antigen binding molecules
0
‌
US Patent 12110338 Site-specific antibody-drug conjugation through glycoengineering
0
‌
US Patent 12110339 ICOS ligand variant immunomodulatory proteins and uses thereof
0
‌
US Patent 12129306 Antibodies binding to STEAP-1
0
‌
US Patent 11654104 Use of IL-22 dimer in manufacture of a medicament for intravenous administration
0
‌
US Patent 11673968 Anti-BRDU antibodies and methods of use
0
‌
US Patent 11673945 Bispecific antigen binding proteins
0
‌
US Patent 11679127 Antigen binding receptors specific for mutated Fc domains
0
‌
US Patent 11685790 Antibodies binding to STEAP-1
0
•••
Patent Inventor Names
Leonard Presta
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
7332581
0
Patent Primary Examiner
‌
Maher M. Haddad
0

Find more entities like US Patent 7332581 Polypeptide variants with altered effector function

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo
By using this site, you agree to our Terms of Service.